Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7809]

Metastasis-promoting circulating tumour cell clusters pass through capillary-sized vessels

Metastasis-promoting circulating tumour cell clusters pass through capillary-sized vessels

AACR 2016: MammaPrint genetic test can reduce use of post-surgery chemotherapy among early-stage, high risk breast cancer patients

AACR 2016: MammaPrint genetic test can reduce use of post-surgery chemotherapy among early-stage, high risk breast...

Evidence showing new drug combination may improve outcomes for women with advanced breast cancer when administered before surgery

Evidence showing new drug combination may improve outcomes for women with advanced breast cancer when administered...

AACR 2016: Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

AACR 2016: Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Researchers identify enzyme link between excessive heart muscle growth, cancer growth

Researchers identify enzyme link between excessive heart muscle growth, cancer growth

Experimental drug guadecitabine found safe in patients with colorectal cancer

Experimental drug guadecitabine found safe in patients with colorectal cancer

Preliminary study: Antibody therapy reduces cancer stem cells in multiple myeloma

Preliminary study: Antibody therapy reduces cancer stem cells in multiple myeloma

AACR 2016: Study shows how TRK-fusion lung cancer escapes LOXO-101, offering new treatment strategies

AACR 2016: Study shows how TRK-fusion lung cancer escapes LOXO-101, offering new treatment strategies

AACR 2016: New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

AACR 2016: New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

AACR 2016: Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

AACR 2016: Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions

More from ecancer